Computex 2025 was light on major launches from AMD, Intel and Nvidia, so we welcomed news about Threadripper 9000, which uses ...

Transferring data seamlessly from an old Mac or Windows PC to your new MacBook Air using Migration Assistant, Move to Mac, or Time Machine restore. Pixabay, josemdelaa Transferring data from an old ...

Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...

During Vertex’s third-quarter presentation, Chief Commercial Officer Duncan McKechnie cited several numbers that suggest the launch of its long-awaited, non-opioid pain reliever Journavx is trending ...

Pre-earnings options volume in Vertex is 2.7x normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 6.1%, or $25.87, after results are released.

President Donald Trump called on the Senate GOP on Thursday to use the “nuclear option” in the upper chamber to reopen the federal government. Trump urged Senate Majority Leader John Thune (R-S.D.) to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A former executive at Microsoft ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

San Francisco, Philadelphia and others are retreating from “harm reduction” strategies that have helped reduce deaths but which critics, including Trump, say have contributed to pervasive public drug ...

There's more good news than bad news for this big biotech stock. Were Vertex's Q2 results horrible? Not at all. Instead, investors reacted negatively after the big biotech company announced two ...